Passage Bio is a Pennsylvania-based biotechnology company that develops and commercializes gene therapies for the treatment of CNS disorders.
Business Model:
Revenue: $0
Employees: 51-200
Address: One Commerce Square, 2005 Market Street,
City: Philadelphia
State: PA
Zip: 19103
Country: US
Passage Bio is a Pennsylvania-based biotechnology company that develops and commercializes gene therapies for the treatment of CNS disorders.
Contact Phone:
+12678660311
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/27/2020
IPO Valuation:
$790M
Ticker Symbol:
PASG
IPO Price:
$18/share
Amount Raised:
$216M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2019 | Series B | 11 | $110M |
Lilly Asia Ventures Highline Capital Management Sphera Funds Management Versant Ventures New Leaf Venture Partners Boxer Capital Len Blavatnik Logos Capital OrbiMed Frazier Healthcare Partners Len Blavatnik Vivo Capital Lilly Asia Ventures Highline Capital Management Sphera Funds Management Versant Ventures New Leaf Venture Partners Boxer Capital Len Blavatnik Logos Capital OrbiMed Frazier Healthcare Partners Len Blavatnik |
2/2019 | Series A | 6 | $115.5M |
OrbiMed Vivo Capital Versant Ventures New Leaf Venture Partners Lilly Asia Ventures Frazier Healthcare Partners OrbiMed |
2/2020 | IPO | $216M |
|
1/2021 | Post-IPO Equity | $154M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|